Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
115.60    0.00 (0.00%)
Bid:
115.80
Ask:
119.40
Spread: 3.60 (3.109%)
Market Cap: £206.21m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

Form 8.3 - TT Electronics PLC

18 Nov 2024 15:20

RNS Number : 6654M
BlackRock Group
18 November 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BlackRock, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TT Electronics plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

15 November 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, Volex plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

25p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

16,183,127

9.10%

0

0.00%

(2) Cash-settled derivatives:

 

1,747,858

0.98%

0

0.00%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00%

0

0.00%

 

TOTAL:

17,930,985

10.08%

0

0.00%

*BlackRock, Inc. does not have voting authority over 906,256 shares, however investment discretion is retained.

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

25p ordinary

Sale

14,713

GBP 1.0950

25p ordinary

Sale

156,544

GBP 1.1000

25p ordinary

Sale

357,869

GBP 1.1039

25p ordinary

Sale

407,982

GBP 1.1090

25p ordinary

Sale

28,198

GBP 1.1100

25p ordinary

Sale

137,380

GBP 1.1155

25p ordinary

Sale

27,278

GBP 1.1175

25p ordinary

Sale

352,492

GBP 1.1292

25p ordinary

Sale

85,862

GBP 1.1300

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

25p ordinary

CFD

Reducing long

158,456

GBP 1.1000

25p ordinary

CFD

Reducing long

36,557

GBP 1.1039

25p ordinary

CFD

Reducing long

41,676

GBP 1.1090

25p ordinary

CFD

Reducing long

2,651

GBP 1.1100

25p ordinary

CFD

Reducing long

22,620

GBP 1.1155

25p ordinary

CFD

Reducing long

4,492

GBP 1.1175

25p ordinary

CFD

Reducing long

36,008

GBP 1.1292

25p ordinary

CFD

Reducing long

14,138

GBP 1.1300

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

25p ordinary

Transfer In of Shares

475,992

25p ordinary

Transfer Out of Shares

475,992

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

18 November 2024

Contact name:

Jana Blumenstein

Telephone number:

+44 20 7743 3650

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFVSLALTLIS
Date   Source Headline
22nd Oct 202412:38 pmRNSHolding(s) in Company
2nd Oct 20247:00 amRNSDirector/PDMR Shareholding
26th Sep 202411:31 amRNSHolding(s) in Company
23rd Sep 20247:00 amRNSHolding(s) in Company
20th Sep 202411:31 amRNSHolding(s) in Company
16th Sep 20247:00 amRNSTrading Update
2nd Sep 20244:43 pmRNSTotal Voting Rights
2nd Sep 20249:00 amRNSNon-Executive Director Succession for AGM 2025
22nd Aug 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSHalf-Year Results
1st Aug 20242:23 pmRNSTotal Voting Rights
29th Jul 20243:44 pmRNSDirector Declaration
24th Jul 202411:39 amRNSDirector Declaration
1st Jul 20243:00 pmRNSTotal Voting Rights
28th Jun 20247:00 amRNSNED Appointment
26th Jun 20242:00 pmRNSNew Reporting Structure
4th Jun 20245:08 pmRNSDirector/PDMR Shareholding
3rd Jun 20242:52 pmRNSTotal Voting Rights
20th May 20245:00 pmRNSHolding(s) in Company
16th May 20243:18 pmRNSHolding(s) in Company
10th May 20243:10 pmRNSAnnual General Meeting Results
10th May 20247:00 amRNSAGM Trading Update
1st May 20242:19 pmRNSBlock listing six monthly return
1st May 20242:16 pmRNSTotal Voting Rights
9th Apr 20247:00 amRNSCapital Markets Event
4th Apr 20245:40 pmRNSAnnual Financial Report
2nd Apr 20247:00 amRNSCompletion of Divestment
19th Mar 20244:44 pmRNSLong Term Incentive Plan
19th Mar 20248:15 amRNSNon-Executive Director Change
15th Mar 20248:30 amRNSDeferred Share Bonus Plan
12th Mar 20249:01 amRNSDeferred Share Bonus Plan
12th Mar 20249:00 amRNSLong Term Incentive Plan
7th Mar 20247:00 amRNSFull Year Results
4th Mar 20247:00 amRNSDivestment of selected business units
1st Mar 20242:25 pmRNSTotal Voting Rights
15th Feb 20243:59 pmRNSTotal Voting Rights
26th Jan 20248:54 amRNSHolding(s) in Company
25th Jan 202411:32 amRNSHolding(s) in Company
22nd Jan 20244:53 pmRNSHolding(s) in Company
3rd Jan 202411:24 amRNSTotal Voting Rights
4th Dec 20239:02 amRNSTotal Voting Rights
24th Nov 202310:36 amRNSDirectorate Change
22nd Nov 20237:00 amRNSTrading Update
15th Nov 20238:36 amRNSBlock Listing Application
3rd Nov 20232:48 pmRNSHolding(s) in Company
30th Oct 20234:45 pmRNSBlock Listing Six Monthly Return
25th Oct 20238:33 amRNSHolding(s) in Company
11th Oct 20238:40 amRNSHolding(s) in Company
2nd Oct 20232:40 pmRNSShare Awards for Incoming Chief Executive Officer
2nd Oct 20238:27 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.